Download scientific diagram | Mecanismo de acción de los antibióticos betalactámicos. Tomado de: (Suárez & Gudiol, ). from publication: Determinación. Antibióticos betalactamicos. Dr. Jairo Cerrato Toxicologo clinico. Penicilinas Cefalosporinas Inhibidores de la Carbapenemicos B-lactamasa. ANTIBIOTICOS BETALACTAMICOS. OC. Osvaldo Cabrera. Updated 13 March Transcript. RESISTENCIA. USOS CLINICOS. AMOXICILINA. DE PRIMERA .

Author: Mobar Vudokora
Country: Serbia
Language: English (Spanish)
Genre: Medical
Published (Last): 14 September 2006
Pages: 157
PDF File Size: 13.16 Mb
ePub File Size: 3.84 Mb
ISBN: 358-8-65880-344-3
Downloads: 68822
Price: Free* [*Free Regsitration Required]
Uploader: Tara

Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.

Safety and efficacy of sequential i. Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.

Int J Antimicrob Agents. La probabilidad que futura evidencia cambie las conclusiones presentadas en este resumen es baja, debido a la certeza de la evidencia. Treatment of community-acquired pneumonia: Nuestros betalactamcos no logran establecer diferencias significativas entre ambas estrategias. Clinical Microbiology and Infection. Trovafloxacin versus high-dose amoxicillin 1 g three times daily in the treatment of community-acquired bacterial pneumonia.


Empirical atypical coverage for inpatients with community-acquired pneumonia: A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Treatment of community-acquired pneumonia with moxifloxacin: Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: Chinese Journal of Antibiotics.


Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified six systematic reviews including 36 randomized trials addressing this question. Scand J Infect Dis. Are new antibiotics better than aantibioticos for non-critical inpatients with community-acquired pneumonia?

Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.

Cochrane Database Syst Rev. We concluded new antibiotics are not better than beta-lactam antibiotics for the treatment of non-critical inpatients with community-acquired pneumonia in relation to clinical failure or adverse effects. Betalwctamicos Sep Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.

Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: Information reported in antibiotocos systematic review, Clinical phase III comparative study of intravenous levofloxacin and ceftriaxone in community-acquired pneumonia treatment. Evaluation of roxithromycin RU versus cephradine in pneumococcal pneumonia.

We combined the evidence using meta-analysis and generated a summary of findings table following the GRADE approach. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: Beta-lactam antibiotics have been traditionally considered first-line therapy.

Study report GFXB Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. Kinasewitz G, Wood RG. Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia?. Treatment for community-acquired pneumonia in immunocompetent adults is mainly empirical.


There was a problem providing the content you requested

Chuard C, Regamey C. Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.

Erythromycin compared with a combination of ampicillin and amoxycillin as initial therapy for adults with pneumonia including Legionnaires’ disease. New antibiotics could be more effective but the evidence is not clear until now, and its use could entail greater costs, an increase in bacterial resistance and other adverse effects.

Planta farmaceutica para antibioticos betalactamicos by Alejandra Ovalle on Prezi

Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. Information reported in a systematic review.